These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 26537232)
1. Prediction of Long-term Post-operative Testosterone Replacement Requirement Based on the Pre-operative Tumor Volume and Testosterone Level in Pituitary Macroadenoma. Lee CC; Chen CM; Lee ST; Wei KC; Pai PC; Toh CH; Chuang CC Sci Rep; 2015 Nov; 5():16194. PubMed ID: 26537232 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma. Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499 [TBL] [Abstract][Full Text] [Related]
4. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
5. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging. Serra C; Burkhardt JK; Esposito G; Bozinov O; Pangalu A; Valavanis A; Holzmann D; Schmid C; Regli L Neurosurg Focus; 2016 Mar; 40(3):E17. PubMed ID: 26926057 [TBL] [Abstract][Full Text] [Related]
13. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts. McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358 [TBL] [Abstract][Full Text] [Related]
14. Transition From Microscopic to Endoscopic Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas. Karppinen A; Kivipelto L; Vehkavaara S; Ritvonen E; Tikkanen E; Kivisaari R; Hernesniemi J; Setälä K; Schalin-Jäntti C; Niemelä M World Neurosurg; 2015 Jul; 84(1):48-57. PubMed ID: 25731792 [TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature. Sodi R; Fikri R; Diver M; Ranganath L; Vora J Ann Clin Biochem; 2005 Mar; 42(Pt 2):153-9. PubMed ID: 15829128 [TBL] [Abstract][Full Text] [Related]
16. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism. George M; Yulia T; Svetlana K Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323 [TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307 [TBL] [Abstract][Full Text] [Related]
20. [Sexual function rehabilitation of men with pituitary tumors]. Rozhivanov RV; Kurbatov DG Urologiia; 2010; (4):48, 50-3. PubMed ID: 20973135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]